|
From the moment COVID-19 emerged as a threat, one approach to making drugs to treat or prevent the disease seemed to hold the most promise: They're known as monoclonal antibodies. Now, scientists are on the brink of getting important data that may indicate whether these desperately needed therapies could be safe and effective. Despite experts' eagerness to see the data, however, there remains a debate over just how significant a role any antibody treatment might play in changing the course of the pandemic.
|